Join
Live feed
·
PRReleasevia Quantisnow
4D Molecular Therapeutics Inc. logo

4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FDMT (4D Molecular Therapeutics Inc.) and more on Quantisnow.